An addiction medicine expert with more than 30 IND filings and two FDA successes, Dr. Beyer will help to advance GATC compounds to human clinical trials. IRVINE, Calif., May 30, 2024 /PRNewswire/ — GATC Health Corp, a technology company advancing drug discovery and disease prediction…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.